Patent · US Active

Hydroxy-substituted gold(III) porphyrin complexes as histone deacetylase inhibitors

US8563712B2 · kind B2 · utility

3Cited by

1References

9Claims

0Family size

Assignee

University of Hong Kong · CN

Inventors

Chi-Ming Che · Hong Kong, CN
Yu Wang · Fishers, US
Raymond Wai-Yin Sun · Hong Kong, CN
Kim Hei-Man Chow · Sha Tin, CN

Key dates

Filing date	Oct 27, 2010
Grant date	Oct 22, 2013
Priority date	—
Expiry date	May 9, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for treatment of cancer by inhibiting the activity of histone deacetylase, comprising administering to a human in need of such treatment a composition containing a therapeutically effective amount of a gold(III) complex having the structural formula ofor a pharmaceutically acceptable salt thereof, wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.